Skip to content
10-Q

Quarterly Report

AXIM BIOTECHNOLOGIES, INC. AXIM

0001096906-24-001772

← back to feed
Filed
Aug 19, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 16, 2024 301.96M sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$514.05K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$785.55K
Long Term Debt Q2 2024 · Jun 30, 2024 $5.97M
Long Term Debt Q2 2024 · Dec 31, 2023 $4.89M
Stockholders Equity Q2 2024 · Jun 30, 2024 −$9.53M
Stockholders Equity Q2 2024 · Mar 31, 2024 −$7.45M
Stockholders Equity Q2 2024 · Dec 31, 2023 −$7.66M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$9.75M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$6.16M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$4.83M
Current Liabilities Q2 2024 · Jun 30, 2024 $6.57M
Current Liabilities Q2 2024 · Dec 31, 2023 $5.98M
Total Liabilities Q2 2024 · Jun 30, 2024 $13.26M
Total Liabilities Q2 2024 · Dec 31, 2023 $11.78M
Current Assets Q2 2024 · Jun 30, 2024 $20.24K
Current Assets Q2 2024 · Dec 31, 2023 $156.46K
Total Assets Q2 2024 · Jun 30, 2024 $3.73M
Total Assets Q2 2024 · Dec 31, 2023 $4.12M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.01
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.01
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.02
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.03
Eps Basic Q2 2024 · Jun 30, 2024 −$0.01
Eps Basic Q2 2024 · Jun 30, 2024 −$0.01
Eps Basic Q2 2024 · Jun 30, 2023 −$0.02
Eps Basic Q2 2024 · Jun 30, 2023 −$0.03
Sga Expense Q2 2024 · Jun 30, 2024 $472.98K
Sga Expense Q2 2024 · Jun 30, 2024 $804.24K
Sga Expense Q2 2024 · Jun 30, 2023 $566.83K
Sga Expense Q2 2024 · Jun 30, 2023 $1.16M
Rd Expense Q2 2024 · Jun 30, 2024 $4.06K
Rd Expense Q2 2024 · Jun 30, 2024 $19.35K
Rd Expense Q2 2024 · Jun 30, 2023 $34.07K
Rd Expense Q2 2024 · Jun 30, 2023 $54.41K
Rd Expense Q2 2024 · Dec 31, 2021 $284.87K
Net Income Q2 2024 · Jun 30, 2024 −$2.27M
Net Income Q2 2024 · Jun 30, 2024 −$2.56M
Net Income Q2 2024 · Mar 31, 2024 −$292.3K
Net Income Q2 2024 · Jun 30, 2023 −$3.72M
Net Income Q2 2024 · Jun 30, 2023 −$6.49M
Net Income Q2 2024 · Mar 31, 2023 −$2.76M
Operating Income Q2 2024 · Jun 30, 2024 −$569.44K
Operating Income Q2 2024 · Jun 30, 2024 −$971.01K
Operating Income Q2 2024 · Jun 30, 2023 −$697.73K
Operating Income Q2 2024 · Jun 30, 2023 −$1.41M
Gross Profit Q2 2024 · Jun 30, 2024 $15.74K
Gross Profit Q2 2024 · Jun 30, 2024 $68.71K
Gross Profit Q2 2024 · Jun 30, 2023 $9.93K
Gross Profit Q2 2024 · Jun 30, 2023 $17.08K
Revenue Q2 2024 · Jun 30, 2024 $17.48K
Revenue Q2 2024 · Jun 30, 2024 $70.46K
Revenue Q2 2024 · Jun 30, 2023 $9.93K
Revenue Q2 2024 · Jun 30, 2023 $17.08K